Temperature Management Linked to Lower Brain Disability After In-Hospital Arrest

Refining Neuroprotection After In-Hospital Cardiac Arrest

Managing post-cardiac arrest syndrome, a complex state of systemic ischemia and reperfusion injury that often leads to multiorgan failure, remains a significant challenge for intensive care clinicians because brain injury typically dictates long-term prognosis [1]. While targeted temperature management (the controlled cooling of a patient to a specific goal temperature to mitigate neuronal injury) is a standard of care, recent trials involving 3,243 patients found no significant difference in six-month mortality (OR 0.88; 95% CI, 0.67 to 1.16) between hypothermia and normothermia [2, 3]. Evidence is particularly inconsistent for in-hospital cardiac arrest, where a meta-analysis of 14,607 patients showed no improvement in survival to discharge (OR 1.02; 95% CI, 0.77 to 1.35) or favorable neurological outcomes [4]. This clinical ambiguity is compounded by the fact that in-hospital populations often present with different comorbidities and lower rates of shockable rhythms than those seen in out-of-hospital events [5]. A new nationwide analysis of 95,337 survivors now addresses these uncertainties, finding that targeted temperature management was independently associated with a 15 percent reduction in the risk of permanent, specialist-certified brain disability (HR 0.85; 95% CI, 0.75 to 0.96) [6].

Defining Irreversible Neurological Impairment

To evaluate the long-term impact of cooling interventions, researchers conducted a nationwide retrospective cohort study utilizing the South Korean National Health Insurance Service database. This comprehensive dataset allowed for the longitudinal tracking of adult in-hospital cardiac arrest survivors over a ten-year period from 2013 to 2022. By leveraging this national registry, the study identified a total of 95,337 eligible survivors, eventually focusing on a matched cohort of 31,592 patients to compare those who received targeted temperature management against those who did not. The study utilized a hard endpoint, which is a definitive and objective clinical outcome, to measure neurological success. This approach moves beyond the subjective or transient scores often used in acute care research that may not reflect a patient's ultimate functional recovery. The primary endpoint was newly diagnosed brain disability registered in the Korea National Disability Registration System. Unlike standard bedside assessments such as the Glasgow Coma Scale, this registry requires stringent certification by board-certified specialists to verify the presence of a permanent impairment. This certification process is only initiated after a patient has completed at least six months of active treatment, a requirement intended to confirm the irreversibility of the neurological deficit. For the practicing clinician, this rigorous definition of disability provides a more meaningful metric than early neurological scales captured at hospital discharge. By requiring a six-month window of treatment and specialist verification, the researchers ensured that the findings reflected true long-term functional status rather than temporary post-arrest encephalopathy. In the propensity score-matched analysis, the targeted temperature management group demonstrated a significantly lower incidence of new-onset brain disability at 5.0 percent, compared to 5.2 percent in the non-TTM group (HR, 0.85; 95% CI, 0.75 to 0.96; P = .012). These data suggest that the neuroprotective effects of controlled cooling extend to the prevention of legally certified, permanent neurological damage.

Analyzing a Matched Cohort of 31,592 Survivors

The researchers began their investigation by identifying a total cohort of 95,337 eligible survivors of adult in-hospital cardiac arrest. To evaluate the clinical impact of cooling interventions, these adult survivors were categorized into two distinct groups: those who received targeted temperature management and those who did not. The primary objective was to investigate the association between the use of targeted temperature management and the subsequent risk of new-onset brain disability, providing a clear picture of how this intervention influences long-term neurological outcomes in a hospital setting. To account for potential confounding variables and ensure a rigorous comparison, the study employed 1:5 propensity score matching (a statistical method that balances patient characteristics between treatment and control groups to mimic the conditions of a randomized controlled trial). This process resulted in a matched cohort of 31,592 patients, consisting of 5,633 individuals in the targeted temperature management group and 25,959 individuals in the non-TTM group. By structuring the cohort in this manner, the authors could more accurately isolate the effect of temperature management on patient recovery while minimizing selection bias. The analysis utilized stratified Cox proportional hazards models (a statistical technique used to estimate the risk of a specific event occurring over time while accounting for different subgroups) to determine the hazard ratios for new-onset disability. This model allowed the researchers to calculate that targeted temperature management was independently associated with a reduced risk of new-onset brain disability (HR, 0.85; 95% CI, 0.75 to 0.96; P = .012). For the clinician, these figures quantify the neuroprotective benefit of cooling, suggesting a 15 percent reduction in the risk of permanent, specialist-certified impairment among survivors of in-hospital cardiac arrest.

Significant Reductions in Permanent Disability

While targeted temperature management is the standard of care for comatose cardiac arrest survivors, evidence regarding its long-term neurological impact specifically on in-hospital cardiac arrest survivors remains limited. This study addresses this clinical uncertainty by examining the incidence of permanent, specialist-certified neurological impairment. In the propensity score-matched cohort, the targeted temperature management group showed a 5.0 percent incidence of new-onset brain disability, compared to a 5.2 percent incidence in the non-TTM group. The primary analysis demonstrated that targeted temperature management was independently associated with a reduced risk of new-onset brain disability (HR, 0.85; 95% CI, 0.75-0.96; P = .012), suggesting a significant neuroprotective benefit for patients who suffer an arrest within the hospital setting. To ensure the robustness of these findings, the researchers performed a multivariable sensitivity analysis (a secondary analysis that tests if the results remain consistent when different variables or assumptions are applied) in the entire cohort of 95,337 survivors. This broader analysis confirmed the protective association, showing an adjusted HR of 0.80 (95% CI, 0.70-0.90; P < .001). These data indicate that targeted temperature management implementation is associated with a decreased risk of legally certified, permanent brain disability in in-hospital cardiac arrest survivors. For clinicians, these results provide evidence that targeted temperature management serves as a neuroprotective strategy to improve long-term quality of survivorship, reducing the likelihood of irreversible neurological deficits that require formal disability registration.

References

1. Zeng R, Lai F, Huang M, et al. Feasibility of electroacupuncture at Baihui (GV20) and Zusanli (ST36) on survival with a favorable neurological outcome in patients with postcardiac arrest syndrome after in-hospital cardiac arrest: study protocol for a pilot randomized controlled trial.. Pilot and feasibility studies. 2023. doi:10.1186/s40814-023-01239-9

2. Shrestha DB, Sedhai YR, Budhathoki P, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest: A systematic review and meta-analysis of randomized controlled trials.. Annals of medicine and surgery (2012). 2022. doi:10.1016/j.amsu.2022.103327

3. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest. New England Journal of Medicine. 2013. doi:10.1056/nejmoa1310519

4. Yin L, Xie D, He D, et al. Survival to hospital discharge and neurological outcomes with targeted temperature management after in-hospital cardiac arrest: a systematic review and meta-analysis.. Annals of palliative medicine. 2022. doi:10.21037/apm-21-3403

5. Shrestha DB, Sedhai YR, Dawadi S, et al. Outcome of In-Hospital Cardiac Arrest among Patients with COVID-19: A Systematic Review and Meta-Analysis.. Journal of clinical medicine. 2023. doi:10.3390/jcm12082796

6. Oh TK, Song I. Association Between Targeted Temperature Management and New-Onset Brain Disability in in-Hospital Cardiac Arrest Survivors: A Nationwide Cohort Study.. Journal of intensive care medicine. 2026. doi:10.1177/08850666261434483